Steven Robert Alberts, MD

  • 15956 Citations
  • 55 Scopus h-Index
1987 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Article

ACCENT-based web calculators to predict recurrence and overall survival in stage III colon cancer

The Adjuvant Colon Cancer Endpoints (ACCENT) Group, Dec 1 2014, In : Journal of the National Cancer Institute. 106, 12

Research output: Contribution to journalArticle

32 Scopus citations

Adjuvant chemoradiotlherapy with epirubicin, cisplatin, and fluorouracil compared with adjuvant chemoradiotherapy with fluorouracil and leucovorin after curative resection of gastric cancer: Results from CALGB 80101 (Alliance)

Fuchs, C. S., Enzinger, P. C., Meyerhardt, J., Mayer, R. J., Mamon, H. J., Swanson, R. S., Niedzwiecki, D., Ye, X., Willett, C. G., Tepper, J. E., Haller, D. G., Dragovich, T., Gunderson, L. L., Alberts, S. R., Bjarnason, G. A., Goldberg, R. M., Ciombor, K., Venook, A. P., Ilson, D., O'Reilly, E. & 1 others, Berg, D. J., Nov 10 2017, In : Journal of Clinical Oncology. 35, 32, p. 3671-3677 7 p.

Research output: Contribution to journalArticle

41 Scopus citations

Adjuvant Chemotherapy for Resected Stage II and III Colon Cancer: Comparison of Two Widely Used Prognostic Calculators

Bardia, A., Loprinzi, C., Grothey, A., Nelson, G., Alberts, S., Menon, S., Thome, S., Gill, S. & Sargent, D., Feb 2010, In : Seminars in oncology. 37, 1, p. 39-46 8 p.

Research output: Contribution to journalArticle

20 Scopus citations

Alcohol consumption and colon cancer prognosis among participants in north central cancer treatment group phase III trial N0147

Phipps, A. I., Shi, Q., Limburg, P. J., Nelson, G. D., Sargent, D. J., Sinicrope, F. A., Chan, E., Gill, S., Goldberg, R. M., Kahlenberg, M., Nair, S., Shields, A. F., Newcomb, P. A. & Alberts, S. R., Sep 1 2016, In : International Journal of Cancer. 139, 5, p. 986-995 10 p.

Research output: Contribution to journalArticle

10 Scopus citations

Alternating systemic and hepatic artery infusion therapy for resected liver metastases from colorectal cancer: A North Central Cancer Treatment Group (NCCTG)/ National Surgical Adjuvant Breast and Bowel Project (NSABP) phase II intergroup trial, N9945/CI-66

Alberts, S. R., Roh, M. S., Mahoney, M. R., O'Connell, M. J., Nagorney, D. M., Wagman, L., Smyrk, T. C., Weiland, T. L., Lai, L. L., Schwarz, R. E., Molina, R., Dentchev, T. & Bolton, J. S., Feb 10 2010, In : Journal of Clinical Oncology. 28, 5, p. 853-858 6 p.

Research output: Contribution to journalArticle

45 Scopus citations

Analysis of Molecular Markers by Anatomic Tumor Site in Stage III Colon Carcinomas from Adjuvant Chemotherapy Trial NCCTG N0147 (Alliance)

for the Alliance for Clinical Trials in Oncology, Dec 1 2015, In : Clinical Cancer Research. 21, 23, p. 5294-5304 11 p.

Research output: Contribution to journalArticle

39 Scopus citations

Analysis of tumor microenvironmental features to refine prognosis by T, N risk group in patients with stage III colon cancer (NCCTG N0147) (Alliance)

Lee, H., Sha, D., Foster, N. R., Shi, Q., Alberts, S. R., Smyrk, T. C. & Sinicrope, F. A., Apr 2020, In : Annals of Oncology. 31, 4, p. 487-494 8 p.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations

Antitumor effect of FGFR inhibitors on a novel cholangiocarcinoma patient derived xenograft mouse model endogenously expressing an FGFR2-CCDC6 fusion protein

Wang, Y., Ding, X., Wang, S., Moser, C. D., Shaleh, H. M., Mohamed, E. A., Chaiteerakij, R., Allotey, L. K., Chen, G., Miyabe, K., McNulty, M. S., Ndzengue, A., Barr Fritcher, E. G., Knudson, R. A., Greipp, P. T., Clark, K. J., Torbenson, M. S., Kipp, B. R., Zhou, J., Barrett, M. T. & 4 others, Gustafson, M. P., Alberts, S. R., Borad, M. J. & Roberts, L. R., Sep 28 2016, In : Cancer Letters. 380, 1, p. 163-173 11 p.

Research output: Contribution to journalArticle

36 Scopus citations

A phase I and pharmacokinetic study of a powder-filled capsule formulation of oral irinotecan (CPT-11) given daily for 5 days every 3 weeks in patients with advanced solid tumors

Pilot, H. C., Adjei, A. A., Reid, J. M., Sloan, J. A., Atherton, P. J., Rubin, J., Alberts, S. R., Duncan, B. A., Denis, L., Schaaf, L. J., Yin, D., Sharma, A., McGovren, P., Miller, L. L. & Erlichman, C., Aug 1 2006, In : Cancer chemotherapy and pharmacology. 58, 2, p. 165-172 8 p.

Research output: Contribution to journalArticle

14 Scopus citations

A phase I and pharmacokinetic study of the selective, non-peptidic inhibitor of matrix metalloproteinase BAY 12-9566 in combination with etoposide and carboplatin

Molina, J. R., Reid, J. M., Erlichman, C., Sloan, J. A., Furth, A., Safgren, S. L., Lathia, C. D. & Alberts, S. R., Oct 1 2005, In : Anti-cancer drugs. 16, 9, p. 997-1002 6 p.

Research output: Contribution to journalArticle

21 Scopus citations

A phase I and pharmacologic study of pyrazoloacridine (NSC 366140) and carboplatin in patients with advanced cancer

Adjei, A. A., Reid, J. M., Erlichman, C., Sloan, J. A., Pitot, H. C., Alberts, S. R., Goldberg, R. M., Hanson, L. J., Ruben, S., Boerner, S. A., Atherton, P., Ames, M. M. & Kaufmann, S. H., Aug 8 2002, In : Investigational New Drugs. 20, 3, p. 297-304 8 p.

Research output: Contribution to journalArticle

6 Scopus citations
35 Scopus citations

A phase I and pharmacologic trial of two schedules of the proteasome inhibitor, PS-341 (Bortezomib, Velcade), in patients with advanced cancer

Dy, G. K., Thomas, J. P., Wilding, G., Bruzek, L., Mandrekar, S., Erlichman, C., Alberti, D., Binger, K., Pitot, H. C., Alberts, S. R., Hanson, L. J., Marnocha, R., Tutsch, K., Kaufmann, S. H. & Adjei, A. A., May 1 2005, In : Clinical Cancer Research. 11, 9, p. 3410-3416 7 p.

Research output: Contribution to journalArticle

63 Scopus citations

A phase IB study of the pharmacokinetics of gemcitabine and pemetrexed, when administered in rapid sequence to patients with advanced solid tumors

Dy, G. K., Suri, A., Reid, J. M., Sloan, J. A., Pitot, H. C., Alberts, S. R., Goldberg, R. M., Atherton, P. J., Hanson, L. J., Burch, P. A., Rubin, J., Erlichman, C. & Adjei, A. A., Jun 1 2005, In : Cancer chemotherapy and pharmacology. 55, 6, p. 522-530 9 p.

Research output: Contribution to journalArticle

22 Scopus citations

A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance)

Halfdanarson, T. R., Foster, N. R., Kim, G. P., Meyers, J. P., Smyrk, T. C., McCullough, A. E., Ames, M. M., Jaffe, J. P. & Alberts, S. R., May 2019, In : Oncologist. 24, 5, p. 589-e160

Research output: Contribution to journalArticle

3 Scopus citations

A phase II study of topical ceramides for cutaneous breast cancer

Jatoi, A., Suman, V. J., Schaefer, P., Block, M., Loprinzi, C., Roche, P., Garneau, S., Morton, R., Stella, P. J., Alberts, S. R., Pittelkow, M., Sloan, J. & Pagano, R., Jul 1 2003, In : Breast Cancer Research and Treatment. 80, 1, p. 99-104 6 p.

Research output: Contribution to journalArticle

14 Scopus citations

A phase II trial of docetaxel and CPT-11 in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and gastric cardia

Jatoi, A., Tirona, M. T., Cha, S. S., Alberts, S. R., Rowland, K. M., Morton, R. F., Nair, S., Kardinal, C. G., Stella, P. J., Mailliard, J. A., Sargent, D. & Goldberg, R. M., 2002, In : International Journal of Gastrointestinal Cancer. 32, 2-3, p. 115-123 9 p.

Research output: Contribution to journalArticle

30 Scopus citations

A phase I study of sequential irinotecan and 5-fluorouracil/leucovorin

Goldberg, R. M., Kaufmann, S. H., Atherton, P., Sloan, J. A., Adjei, A. A., Pitot, H. C., Alberts, S. R., Rubin, J., Miller, L. L. & Erlichman, C., Oct 2002, In : Annals of Oncology. 13, 10, p. 1674-1680 7 p.

Research output: Contribution to journalArticle

11 Scopus citations

A phase I trial of immunotherapy with lapuleucel-T (APC8024) in patients with refractory metastatic tumors that express HER-2/neu

Peethambaram, P. P., Melisko, M. E., Rinn, K. J., Alberts, S. R., Provost, N. M., Jones, L. A., Sims, R. B., Lin, L. R. C., Frohlich, M. W. & Park, J. W., Sep 15 2009, In : Clinical Cancer Research. 15, 18, p. 5937-5944 8 p.

Research output: Contribution to journalArticle

47 Scopus citations

A phase I trial of ISIS 2503, an antisense inhibitor of H-ras, in combination with gemcitabine in patients with advanced cancer

Adjei, A. A., Dy, G. K., Erlichman, C., Reid, J. M., Sloan, J. A., Pitot, H. C., Alberts, S. R., Goldberg, R. M., Hanson, L. J., Atherton, P. J., Watanabe, T., Geary, R. S., Holmlund, J. & Dorr, F. A., Jan 1 2003, In : Clinical Cancer Research. 9, 1 I, p. 115-123 9 p.

Research output: Contribution to journalArticle

78 Scopus citations

A phase I trial of the farnesyl protein transferase inhibitor R115777 in combination with gemcitabine and cisplatin in patients with advanced cancer

Adjei, A. A., Croghan, G. A., Erlichman, C., Marks, R. S., Reid, J. M., Sloan, J. A., Pitot, H. C., Alberts, S. R., Goldberg, R. M., Hanson, L. J., Bruzek, L. M., Atherton, P., Thibault, A., Palmer, P. A. & Kaufmann, S. H., Jul 1 2003, In : Clinical Cancer Research. 9, 7, p. 2520-2526 7 p.

Research output: Contribution to journalArticle

47 Scopus citations

A pilot study assessing social support among cancer patients enrolled on clinical trials: A comparison of younger versus older adults

Novotny, P. J., Smith, D. J., Guse, L., Rummans, T. A., Hartmann, L., Alberts, S., Goldberg, R., Gregory, D., Johnson, M. & Sloan, J. A., 2010, In : Cancer Management and Research. 2, 1, p. 133-142 10 p.

Research output: Contribution to journalArticle

Open Access
5 Scopus citations

A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer

Goldberg, R. M., Sargent, D. J., Morton, R. F., Fuchs, C. S., Ramanathan, R. K., Williamson, S. K., Findlay, B. P., Pitot, H. C. & Alberts, S. R., Dec 1 2004, In : Journal of Clinical Oncology. 22, 1, p. 23-30 8 p.

Research output: Contribution to journalArticle

1961 Scopus citations

Association between disease-free survival and overall survival when survival is prolonged after recurrence in patients receiving cytotoxic adjuvant therapy for colon cancer: Simulations based on the 20,800 patient ACCENT data set

De Gramont, A., Hubbard, J., Shi, Q., O'Connell, M. J., Buyse, M., Benedetti, J., Bot, B., O'Callaghan, C., Yothers, G., Goldberg, R. M., Blanke, C. D., Benson, A., Deng, Q., Alberts, S. R., Andre, T., Wolmark, N., Grothey, A. & Sargent, D., Jan 20 2010, In : Journal of Clinical Oncology. 28, 3, p. 460-465 6 p.

Research output: Contribution to journalArticle

56 Scopus citations

Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance)

Lee, A. M., Shi, Q., Alberts, S. R., Sargent, D. J., Sinicrope, F. A., Berenberg, E. L., Grothey, A., Polite, B., Chan, E., Gill, S., Kahlenberg, M. S., Nair, S. G., Shields, A. F., Goldberg, R. M. & Diasio, R. B., 2016, In : Pharmacogenetics and genomics. 26, 3, p. 133-137 5 p.

Research output: Contribution to journalArticle

19 Scopus citations

Association between treatment facility volume, therapy types and overall survival in patients with intrahepatic cholangiocarcinoma

Kommalapati, A., Tella, S. H., Goyal, G., Borad, M., Alberts, S. R., Roberts, L., Hubbard, J. M., Durgin, L., Cleary, S. & Mahipal, A., Mar 2019, In : HPB. 21, 3, p. 379-386 8 p.

Research output: Contribution to journalArticle

1 Scopus citations

Association of DNA mismatch repair and mutations in BRAF and KRAS with survival after recurrence in stage III colon cancers: A secondary analysis of 2 randomized clinical trials

Sinicrope, F. A., Shi, Q., Allegra, C. J., Smyrk, T. C., Thibodeau, S. N., Goldberg, R. M., Meyers, J. P., Pogue-Geile, K. L., Yothers, G., Sargent, D. J. & Alberts, S. R., 2017, In : JAMA Oncology. 3, 4, p. 472-480 9 p.

Research output: Contribution to journalArticle

44 Scopus citations

Associations between cigarette smoking status and colon cancer prognosis among participants in North Central Cancer Treatment Group Phase III Trial N0147

Phipps, A. I., Shi, Q., Newcomb, P. A., Nelson, G. D., Sargent, D. J., Alberts, S. R. & Limburg, P. J., Jun 1 2013, In : Journal of Clinical Oncology. 31, 16, p. 2016-2023 8 p.

Research output: Contribution to journalArticle

36 Scopus citations
35 Scopus citations

Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: Results from the Eastern Cooperative Oncology Group Study E3200

Giantonio, B. J., Catalano, P. J., Meropol, N. J., O'Dwyer, P. J., Mitchell, E. P., Alberts, S. R., Schwartz, M. A. & Benson, A. B., Apr 20 2007, In : Journal of Clinical Oncology. 25, 12, p. 1539-1544 6 p.

Research output: Contribution to journalArticle

1830 Scopus citations

Borderline resectable pancreatic cancer: Need for standardization and methods for optimal clinical trial design

Katz, M. H. G., Marsh, R., Herman, J. M., Shi, Q., Collison, E., Venook, A. P., Kindler, H. L., Alberts, S. R., Philip, P., Lowy, A. M., Pisters, P. W. T., Posner, M. C., Berlin, J. D. & Ahmad, S. A., Aug 2013, In : Annals of surgical oncology. 20, 8, p. 2787-2795 9 p.

Research output: Contribution to journalArticle

186 Scopus citations

Bortezomib, paclitaxel, and carboplatin as a first-line regimen for patients with metastatic esophageal, gastric, and gastroesophageal cancer: Phase II results from the north central cancer treatment group (N044B)

Jatoi, A., Dakhil, S. R., Foster, N. R., Ma, C., Rowland, K. M., Moore, D. F., Jaslowski, A. J., Thomas, S. P., Hauge, M. D., Flynn, P. J., Stella, P. J. & Alberts, S. R., May 2008, In : Journal of Thoracic Oncology. 3, 5, p. 516-520 5 p.

Research output: Contribution to journalArticle

29 Scopus citations

Building a protocol expressway: The case of Mayo Clinic Cancer Center

McJoynt, T. A., Hirzallah, M. A., Satele, D. V., Pitzen, J. H., Alberts, S. R. & Rajkumar, S. V., Aug 10 2009, In : Journal of Clinical Oncology. 27, 23, p. 3855-3860 6 p.

Research output: Contribution to journalArticle

14 Scopus citations

Cediranib (AZD2171) in patients with advanced hepatocellular carcinoma: A phase II north central cancer treatment group clinical trial

Alberts, S. R., Fitch, T. R., Kim, G. P., Morlan, B. W., Dakhil, S. R., Gross, H. M. & Nair, S., Aug 2012, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 35, 4, p. 329-333 5 p.

Research output: Contribution to journalArticle

40 Scopus citations

Chemoprevention for prostatic carcinoma: The role of flutamide in patients with prostatic intraepithelial neoplasia

Alberts, S. R. & Blute, M. L., 2001, In : Urology. 57, 4 SUPPL. 1, p. 188-190 3 p.

Research output: Contribution to journalArticle

17 Scopus citations

Chemotherapy permits resection of metastatic colorectal cancer: Experience from intergroup N9741

Delaunoit, T., Alberts, S. R., Sergent, D. J., Green, E., Goldberg, R. M., Krook, J., Fuchs, C., Ramanathan, R. K., Williamson, S. K., Morton, R. F. & Findlay, B. P., Mar 2005, In : Annals of Oncology. 16, 3, p. 425-429 5 p.

Research output: Contribution to journalArticle

139 Scopus citations

Clinical impact of celiac ganglia metastasis upon pancreatic ductal adenocarcinoma

Malikowski, T., Lehrke, H. D., Henry, M. R., Gleeson, F. C., Alberts, S. R., Kendrick, M., Lennon, R. J., McWilliams, R. R., Takahashi, N., Topazian, M. D., Gara, N., Abu Dayyeh, B. K., Chandrasekhara, V., Chari, S. T., Iyer, P. G., Rajan, E., Storm, A. C., Wang, K. K. & Levy, M. J., Jan 1 2019, (Accepted/In press) In : Pancreatology.

Research output: Contribution to journalArticle

Clinical outcomes in patients with colon cancer with microsatellite instability of sporadic or familial origin treated with adjuvant FOLFOX with or without cetuximab: A pooled analysis of the PETACC8 and N0147 trials

Zaanan, A., Shi, Q., Taieb, J., Alberts, S. R., Meyers, J. P., Smyrk, T. C., Julie, C., Zawadi, A., Tabernero, J., Mini, E., Goldberg, R. M., Folprecht, G., van Laethem, J. L., Le Malicot, K., Sargent, D. J., Laurent-Puig, P. & Sinicrope, F. A., 2019, In : JCO Precision Oncology. 3, p. 116-122 7 p.

Research output: Contribution to journalArticle

Clinical predictors of severe cetuximab-induced rash: Observations from 933 patients enrolled in north central cancer treatment group study N0147

Jatoi, A., Green, E. M., Rowland, K. M., Sargent, D. J. & Alberts, S. R., Aug 1 2008, In : Oncology. 77, 2, p. 120-123 4 p.

Research output: Contribution to journalArticle

52 Scopus citations

Clustering of hepatocellular carcinoma in Alaska Native families

Alberts, S. R., Lanier, A. P., McMahon, B. J., Harpster, A., Bulkow, L. R., Heyward, W. L., Murray, C. & Vogler, G. P., 1991, In : Genetic epidemiology. 8, 2, p. 127-139 13 p.

Research output: Contribution to journalArticle

27 Scopus citations

Colorectal cancer in Alaska native people, 2005-2009

Kelly, J. J., Alberts, S. R., Sacco, F. & Lanier, A. P., Sep 1 2012, In : Gastrointestinal Cancer Research. 5, 5, p. 149-154 6 p.

Research output: Contribution to journalArticle

22 Scopus citations

Combined Celiac Ganglia and Plexus Neurolysis Shortens Survival, Without Benefit, vs Plexus Neurolysis Alone

Levy, M. J., Gleeson, F. C., Topazian, M. D., Fujii-Lau, L. L., Enders, F. T., Larson, J. J., Mara, K., Abu Dayyeh, B. K., Alberts, S. R., Hallemeier, C. L., Iyer, P. G., Kendrick, M. L., Mauck, W. D., Pearson, R. K., Petersen, B. T., Rajan, E., Takahashi, N., Vege, S. S., Wang, K. K. & Chari, S. T., Mar 2019, In : Clinical Gastroenterology and Hepatology. 17, 4, p. 728-738.e9

Research output: Contribution to journalArticle

4 Scopus citations

Combined modality therapy including intraoperative electron irradiation for locally recurrent colorectal cancer

Haddock, M. G., Miller, R. C., Nelson, H., Pemberton, J. H., Dozois, E. J., Alberts, S. R. & Gunderson, L. L., Jan 1 2011, In : International Journal of Radiation Oncology Biology Physics. 79, 1, p. 143-150 8 p.

Research output: Contribution to journalArticle

88 Scopus citations

Comparative Economics of a 12-Gene Assay for Predicting Risk of Recurrence in Stage II Colon Cancer

Alberts, S. R., Yu, T. M., Behrens, R. J., Renfro, L. A., Srivastava, G., Soori, G. S., Dakhil, S. R., Mowat, R. B., Kuebler, J. P., Kim, G. P., Mazurczak, M. A. & Hornberger, J., Nov 26 2014, In : PharmacoEconomics. 32, 12, p. 1231-1243 13 p.

Research output: Contribution to journalArticle

8 Scopus citations

Comparative pharmacokinetic study of continuous venous infusion fluorouracil and oral fluorouracil with eniluracil in patients with advanced solid tumors

Adjei, A. A., Reid, J. M., Diasio, R. B., Sloan, J. A., Smith, D. A., Rubin, J., Pitot, H. C., Alberts, S. R., Goldberg, R. M., Hanson, L. J., Atherton, P., Ames, M. M. & Erlichman, C., Mar 15 2002, In : Journal of Clinical Oncology. 20, 6, p. 1683-1691 9 p.

Research output: Contribution to journalArticle

29 Scopus citations

Comparison of estrogen receptor determinations by a biochemical ligand- binding assay and immunohistochemical staining with monoclonal antibody ER1D5 in females with lymph node positive breast carcinoma entered on two prospective clinical trials

Alberts, S. R., Ingle, J. N., Roche, P. R., Cha, S. S., Wold, L. E., Farr, G. H., Krook, J. E. & Wieand, H. S., Aug 15 1996, In : Cancer. 78, 4, p. 764-772 9 p.

Research output: Contribution to journalArticle

61 Scopus citations

Comparison of FOLFIRI with or without cetuximab in patients with resected stage III colon cancer; NCCTG (Alliance) intergroup trial N0147

Huang, J., Nair, S. G., Mahoney, M. R., Nelson, G. D., Shields, A. F., Chan, E., Goldberg, R. M., Gill, S., Kahlenberg, M. S., Quesenberry, J. T., Thibodeau, S. N., Smyrk, T. C., Grothey, A., Sinicrope, F. A., Webb, T. A., Farr, G. H., Pockaj, B. A., Berenberg, J. L., Mooney, M., Sargent, D. J. & 1 others, Alberts, S. R., Jun 2014, In : Clinical colorectal cancer. 13, 2, p. 100-109 10 p.

Research output: Contribution to journalArticle

34 Scopus citations

CPT-11 for bile-duct and gallbladder carcinoma: A phase II North Central Cancer Treatment Group (NCCTG) study

Alberts, S. R., Fishkin, P. A., Burgart, L. J., Cera, P. J., Mahoney, M. R., Morton, R. F., Johnson, P. A., Nair, S. & Goldberg, R. M., 2002, In : International Journal of Gastrointestinal Cancer. 32, 2-3, p. 107-114 8 p.

Research output: Contribution to journalArticle

30 Scopus citations

Current use and surgical efficacy of laparoscopic colectomy in colon cancer

Sticca, R. P., Alberts, S. R., Mahoney, M. R., Sargent, D. J., Finstuen, L. M., Nelson, G. D., Husted, T. M., Franko, J., Goldman, C. D. & Pockaj, B. A., Jul 2013, In : Journal of the American College of Surgeons. 217, 1, p. 56-62 7 p.

Research output: Contribution to journalArticle

13 Scopus citations

Determinants of earlymortality among 37,568 patientswith colon cancerwho participated in 25 clinical trials from the adjuvant colon cancer endpoints database

Cheung, W. Y., Renfro, L. A., Kerr, D., De Gramont, A., Saltz, L. B., Grothey, A., Alberts, S. R., Andre, T., Guthrie, K. A., Labianca, R., Francini, G., Seitz, J. F., O'Callaghan, C., Twelves, C., Van Cutsem, E., Haller, D. G., Yothers, G. & Sargent, D. J., Apr 10 2016, In : Journal of Clinical Oncology. 34, 11, p. 1182-1189 8 p.

Research output: Contribution to journalArticle

14 Scopus citations